EyePoint Pharmaceuticals, Inc. — Director's Dealing 2016

Nov 4, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2016-11-02

Reporting Person: JORN DEBORA (EVP, Corp. & Comm'l Dev.)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-11-02	Stock Option (Right to Buy)	$1.91	A	300000	Acquired	2026-11-02	Common Stock (300000)	Direct

Footnotes

F1: Options to purchase 75,000 shares shall vest and become exercisable on each of the first, second, third and fourth anniversaries, respectively, of the date of grant.